Galectin Therapeutics CEO Joel Lewis' 2021 pay jumps 55% to $1.2M
Galectin Therapeutics reports 2021 executive compensation
By ExecPay News
Published: October 17, 2022
Galectin Therapeutics reported fiscal year 2021 executive compensation information on October 17, 2022.
In 2021, three executives at Galectin Therapeutics received on average a compensation package of $932K, a 9% increase compared to previous year.
Average pay of disclosed executives at Galectin Therapeutics
Joel Lewis, Chief Executive Officer, received $1.2M in total, which increased by 55% compared to 2020. 43% of Lewis' compensation, or $500K, was in salary. Lewis also received $250K in bonus, $329K in option awards, as well as $88K in other compensation.
Pol F. Boudes, Chief Medical Officer, received a compensation package of $924K, which decreased by 15% compared to previous year. 49% of the compensation package, or $453K, was in salary.
Jack W. Callicutt, Chief Financial Officer, earned $706K in 2021, a 2% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on October 17, 2022.